Zijlmans J - Search Results

1

[123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease.

Zijlmans J, Evans A, Fontes F, Katzenschlager R, Gacinovic S, Lees AJ, Costa D. Zijlmans J, et al. Mov Disord. 2007 Jul 15;22(9):1278-85. doi: 10.1002/mds.21479. Mov Disord. 2007. PMID: 17486613

2

The L-dopa response in vascular parkinsonism.

Zijlmans JC, Katzenschlager R, Daniel SE, Lees AJ. Zijlmans JC, et al. J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):545-7. doi: 10.1136/jnnp.2003.018309. J Neurol Neurosurg Psychiatry. 2004. PMID: 15026493 Free PMC article.

3

Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway.

Zijlmans J, Booij J, Valk J, Lees A, Horstink M. Zijlmans J, et al. Mov Disord. 2002 Sep;17(5):1086-8. doi: 10.1002/mds.10203. Mov Disord. 2002. PMID: 12360565

4

[123I]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor.

Katzenschlager R, Costa D, Gerschlager W, O'Sullivan J, Zijlmans J, Gacinovic S, Pirker W, Wills A, Bhatia K, Lees AJ, Brown P. Katzenschlager R, et al. Among authors: zijlmans j. Ann Neurol. 2003 Apr;53(4):489-96. doi: 10.1002/ana.10475. Ann Neurol. 2003. PMID: 12666116 Clinical Trial.

5

Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis.

Zijlmans JC, Daniel SE, Hughes AJ, Révész T, Lees AJ. Zijlmans JC, et al. Mov Disord. 2004 Jun;19(6):630-40. doi: 10.1002/mds.20083. Mov Disord. 2004. PMID: 15197700

6

Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study.

Zijlmans JC, Debilly B, Rascol O, Lees AJ, Durif F. Zijlmans JC, et al. Mov Disord. 2004 Sep;19(9):1006-1011. doi: 10.1002/mds.20188. Mov Disord. 2004. PMID: 15372589 Clinical Trial.

7

Olfactory function distinguishes vascular parkinsonism from Parkinson's disease.

Katzenschlager R, Zijlmans J, Evans A, Watt H, Lees AJ. Katzenschlager R, et al. Among authors: zijlmans j. J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1749-52. doi: 10.1136/jnnp.2003.035287. J Neurol Neurosurg Psychiatry. 2004. PMID: 15548497 Free PMC article. Clinical Trial.

8

Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.

Jahanshahi M, Jones CR, Zijlmans J, Katzenschlager R, Lee L, Quinn N, Frith CD, Lees AJ. Jahanshahi M, et al. Among authors: zijlmans j. Brain. 2010 Mar;133(Pt 3):727-45. doi: 10.1093/brain/awq012. Brain. 2010. PMID: 20305278

9

The clinical features of pathologically confirmed vascular parkinsonism.

Glass PG, Lees AJ, Bacellar A, Zijlmans J, Katzenschlager R, Silveira-Moriyama L. Glass PG, et al. Among authors: zijlmans j. J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):1027-9. doi: 10.1136/jnnp-2012-302828. J Neurol Neurosurg Psychiatry. 2012. PMID: 22960987

10

[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.

Gerschlager W, Bencsits G, Pirker W, Bloem BR, Asenbaum S, Prayer D, Zijlmans JC, Hoffmann M, Brücke T. Gerschlager W, et al. Mov Disord. 2002 May;17(3):518-23. doi: 10.1002/mds.10092. Mov Disord. 2002. PMID: 12112200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters